How does one decide the best pharmacotherapeutic strategy for bacterial peritonitis?

References

• Maraolo AE , Gentile I , Pinchera B , et al. Current and emerging pharmacotherapy for the treatment of bacterial peritonitis. Expert Opin Pharmacother. 2018;19:1317–1325.
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver . EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53:397–417.
   PubMed Web of Science ®Google Scholar
• Fiore M , Gentile I , Maraolo AE , et al. Are third-generation cephalosporins still the empirical antibiotic treatment of community-acquired spontaneous bacterial peritonitis? A systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2018;30:329–336.
   PubMed Web of Science ®Google Scholar
• Fiore M , Maraolo AE , Gentile I , et al. Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis. World J Hepatol. 2017;9:1166–1175.
   PubMed Web of Science ®Google Scholar
• Akoh JA. Peritoneal dialysis associated infections: an update on diagnosis and management. World J Nephrol. 2012;1:106.
   PubMedGoogle Scholar
• Kim JJ , Tsukamoto MM , Mathur AK , et al. Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis. Am J Gastroenterol. 2014;109:1436–1442.
   PubMed Web of Science ®Google Scholar
• Karvellas CJ , Abraldes JG , Arabi YM , et al. Appropriate and timely antimicrobial therapy in cirrhotic patients with spontaneous bacterial peritonitis-associated septic shock: a retrospective cohort study. Aliment Pharmacol Ther. 2015;41:747–757.
   PubMed Web of Science ®Google Scholar
• Dever JB , Sheikh MY. Review article: spontaneous bacterial peritonitis–bacteriology, diagnosis, treatment, risk factors and prevention. Aliment Pharmacol Ther. 2015;41:1116–1131.
   PubMed Web of Science ®Google Scholar
• Wiest R , Krag A , Gerbes A. Spontaneous bacterial peritonitis: recent guidelines and beyond. Gut. 2012;61:297–310.
   PubMed Web of Science ®Google Scholar
• Lutz P , Nischalke HD , Krämer B , et al. Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis. Eur J Clin Invest. 2017;47:44–52.
   PubMed Web of Science ®Google Scholar
• Piano S , Fasolato S , Salinas F , et al. The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial. Hepatol Baltim Md. 2016;63:1299–1309.
   PubMed Web of Science ®Google Scholar
• McLaughlin M , Advincula MR , Malczynski M , et al. Correlations of antibiotic use and carbapenem resistance in Enterobacteriaceae. Antimicrob Agents Chemother. 2013;57:5131–5133.
   PubMed Web of Science ®Google Scholar
• Chuang Y-C , Lin H-Y , Chen P-Y , et al. Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose. Clin Microbiol Infect. 2016;22:890.e1–890.e7.
   Web of Science ®Google Scholar
• Angeli P , Bernardi M , Villanueva C , et al. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. [Internet]. 2018 [cited 2018 Jul 16 ]. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0168827818319664.
   Web of Science ®Google Scholar
• Fernández J , Acevedo J , Castro M , et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatol Baltim Md. 2012;55:1551–1561.
   PubMed Web of Science ®Google Scholar